Fund Holdings — DIADEMA PARTNERS LP

Total Portfolio Value
$167.91M
Total Bought
$111.57M
Total Sold
$87.45M
Net Transaction
+$24.12M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
JOHNSON & JOHNSON(JNJ)066,444+66,444013,7518.19%+13,751
TERNS PHARMACEUTICALS INC323,159345,880+22,7212,42713,9748.32%+11,547
VIKING THERAPEUTICS INC(VKTX)193,689336,849+143,1605,09011,8507.06%+6,760
ABIVAX SA(ABVX)41,62075,644+34,0243,51310,2016.08%+6,688
BRIDGEBIO PHARMA INC(BBIO)070,000+70,00005,3543.19%+5,354
UNITED THERAPEUTICS CORP DEL(UTHR)010,000+10,00004,8732.90%+4,873
CAPRICOR THERAPEUTICS INC(CAPR)0158,075+158,07504,5622.72%+4,562
VERTEX PHARMACEUTICALS INC(VRTX)010,000+10,00004,5342.70%+4,534
BIOAGE LABS INC(BIOA)0271,164+271,16403,5882.14%+3,588
CORCEPT THERAPEUTICS INC(CORT)097,445+97,44503,3912.02%+3,391
COGENT BIOSCIENCES INC(COGT)97,813131,852+34,0391,4054,6832.79%+3,279
TENAX THERAPEUTICS INC(TENX)0243,170+243,17002,9641.77%+2,964
IRONWOOD PHARMACEUTICALS INC(IRWD)0683,611+683,61102,3041.37%+2,304
CENTESSA PHARMACEUTICALS PLC090,000+90,00002,2511.34%+2,251
REPLIMUNE GROUP INC(REPL)0230,997+230,99702,2451.34%+2,245
ELI LILLY & CO(LLY)02,000+2,00002,1491.28%+2,149
LIPOCINE INC NEW(LPCN)0260,939+260,93902,0951.25%+2,095
RELMADA THERAPEUTICS INC(RLMD)0389,395+389,39501,8811.12%+1,881
ANNEXON INC(ANNX)0350,000+350,00001,7571.05%+1,757
VENTYX BIOSCIENCES INC71,204200,000+128,7962211,8061.08%+1,585
INVENTIVA SA(IVA)0334,251+334,25101,5540.93%+1,554
BIOCRYST PHARMACEUTICALS INC(BCRX)0190,928+190,92801,4890.89%+1,489
TG THERAPEUTICS INC(TGTX)60,748123,283+62,5352,1953,6752.19%+1,481
ANI PHARMACEUTICALS INC(ANIP)31,40053,354+21,9542,8764,2122.51%+1,336
RIGEL PHARMACEUTICALS INC(RIGL)030,000+30,00001,2850.77%+1,285
MAPLIGHT THERAPEUTICS INC(MPLT)063,791+63,79101,1200.67%+1,120
UNIQURE NV(QURE)045,000+45,00001,0770.64%+1,077
ENANTA PHARMACEUTICALS INC(ENTA)065,138+65,13801,0270.61%+1,027
PROTHENA CORP PLC
SHS
0106,539+106,53901,0170.61%+1,017
MONTE ROSA THERAPEUTICS INC(GLUE)062,281+62,28109770.58%+977
DESIGN THERAPEUTICS INC(DSGN)0100,320+100,32009410.56%+941
INOVIO PHARMACEUTICALS INC(INO)0533,682+533,68209290.55%+929
MINERALYS THERAPEUTICS INC(MLYS)025,000+25,00009070.54%+907
LIQUIDIA CORPORATION(LQDA)021,881+21,88107550.45%+755
EDGEWISE THERAPEUTICS INC(EWTX)030,000+30,00007440.44%+744
XERIS BIOPHARMA HOLDINGS INC74,753170,568+95,8156081,3390.80%+730
VIRIDIAN THERAPEUTICS INC(VRDN)021,114+21,11406570.39%+657
VIR BIOTECHNOLOGY INC(VIR)0100,000+100,00006030.36%+603
MANNKIND CORP(MNKD)212,475302,000+89,5251,1411,7121.02%+571
LIGAND PHARMACEUTICALS INC(LGND)02,987+2,98705650.34%+565
UPSTREAM BIO INC(UPB)020,500+20,50005570.33%+557
STOKE THERAPEUTICS INC(STOK)017,181+17,18105450.32%+545
IMMUNOME INC(IMNM)022,500+22,50004830.29%+483
PELTHOS THERAPEUTICS INC(PTHS)10,49825,000+14,5022947750.46%+481
TREVI THERAPEUTICS INC(TRVI)85,83097,184+11,3547851,2170.72%+431
PALISADE BIO INC(PALI)0166,049+166,04903900.23%+390
AYTU BIOPHARMA INC272,670305,788+33,1185137950.47%+282
AARDVARK THERAPEUTICS INC015,882+15,88202080.12%+208
REVOLUTION MEDICINES INC(RVMD)59,07937,020-22,0592,7592,9491.76%+190
PLIANT THERAPEUTICS INC(PLRX)0144,914+144,91401770.11%+177
BEONE MEDICINES LTD(ONC)07,500+7,50001730.10%+173
TALPHERA INC(TLPH)0136,923+136,92301560.09%+156
EQUILLIUM INC(EQ)300,000347,393+47,3934295380.32%+109
INHIBRX BIOSCIENCES INC(INBX)01,299+1,29901030.06%+103
EDESA BIOTECH INC(EDSA)054,025+54,0250770.05%+77
PROQR THRAPEUTICS N V
SHS EURO
157,694167,532+9,8383363380.20%+3
PURETECH HEALTH PLC(PRTCY)7,3247,442+1181351240.07%-12
PMV PHARMACEUTICALS INC(PMVP)11,3000-11,300160—-16
NEUPHORIA THERAPEUTICS INC21,45250,000+28,5482531940.12%-59
FOGHORN THERAPEUTICS INC(FHTX)50,00030,630-19,3702451650.10%-79
TVARDI THERAPEUTICS INC(TVRD)2,1850-2,185850—-85
ANAPTYSBIO INC3,2950-3,2951010—-101
RELAY THERAPEUTICS INC(RLAY)43,6160-43,6162280—-228
OVID THERAPEUTICS INC(OVID)187,7390-187,7392440—-244
CLIMB BIO INC(CLYM)136,4880-136,4882740—-274
PACIRA BIOSCIENCES INC(PCRX)58,92648,025-10,9011,5191,2430.74%-276
ULTRAGENYX PHARMACEUTICAL IN(RARE)9,1890-9,1892760—-276
PYXIS ONCOLOGY INC(PYXS)150,0000-150,0003330—-333
ALECTOR INC136,0230-136,0234030—-403
TENAYA THERAPEUTICS INC(TNYA)315,5190-315,5195110—-511
MODERNA INC(MRNA)20,0000-20,0005170—-517
CYTOMX THERAPEUTICS INC(CTMX)185,2860-185,2865910—-591
ARDELYX INC400,000252,198-147,8022,2041,4700.88%-734
ARCTURUS THERAPEUTICS HLDGS(ARCT)48,8110-48,8119000—-900
REVIVA PHARMACEUTCLS HLDGS I2,506,9210-2,506,9219240—-924
CATALYST PHARMACEUTICALS INC50,0000-50,0009850—-985
SUPERNUS PHARMACEUTICALS INC(SUPN)22,3480-22,3481,0680—-1,068
HARMONY BIOSCIENCES HLDGS IN(HRMY)50,0007,500-42,5001,3782810.17%-1,097
VISTAGEN THERAPEUTICS INC(VTGN)349,789100,000-249,7891,242660.04%-1,176
MIND MEDICINE MINDMED INC105,8910-105,8911,2480—-1,248
UROGEN PHARMA LTD(URGN)90,00021,810-68,1901,7965110.30%-1,285
AVIDITY BIOSCIENCES INC30,0000-30,0001,3070—-1,307
AMYLYX PHARMACEUTICALS INC(AMLX)100,0000-100,0001,3590—-1,359
NOVO-NORDISK A S(NVO)25,0000-25,0001,3870—-1,387
PROTAGONIST THERAPEUTICS INC51,18522,700-28,4853,4001,9831.18%-1,418
ROIVANT SCIENCES LTD(ROIV)120,0000-120,0001,8160—-1,816
IMMUNOCORE HLDGS PLC(IMCR)124,38470,300-54,0844,5192,4401.45%-2,079
ALKERMES PLC(ALKS)72,0790-72,0792,1620—-2,162
ALNYLAM PHARMACEUTICALS INC(ALNY)10,0005,341-4,6594,5602,1241.26%-2,436
APOGEE THERAPEUTICS INC(APGE)64,2500-64,2502,5530—-2,553
BIOMARIN PHARMACEUTICAL INC(BMRN)212,877146,361-66,51611,5298,6985.18%-2,831
JAZZ PHARMACEUTICALS PLC(JAZZ)23,1400-23,1403,0500—-3,050
ASCENDIS PHARMA A/S(ASND)27,5726,840-20,7325,4821,4590.87%-4,023
NEKTAR THERAPEUTICS(NKTR)75,0000-75,0004,2680—-4,267
NEUROCRINE BIOSCIENCES INC(NBIX)37,7540-37,7545,3000—-5,300
INDIVIOR PLC254,25217,320-236,9326,1306210.37%-5,509
BRISTOL-MYERS SQUIBB CO(BMY)130,0000-130,0005,8630—-5,863
VAXCYTE INC(PCVX)218,28522,972-195,3137,8631,0600.63%-6,803
REGENERON PHARMACEUTICALS(REGN)30,16010,300-19,86016,9587,9504.73%-9,008
SOLENO THERAPEUTICS INC177,33026,892-150,43811,9881,2450.74%-10,742
Page 1 of 1
DIADEMA PARTNERS LP — 13F Holdings — Q4 2025 | TickerTrail